Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2025)
Viemed Healthcare's Liabilities and Shareholders Equity history spans 8 years, with the latest figure at $199.2 million for Q4 2025.
- For Q4 2025, Liabilities and Shareholders Equity rose 12.47% year-over-year to $199.2 million; the TTM value through Dec 2025 reached $764.2 million, up 14.84%, while the annual FY2025 figure was $199.2 million, 12.47% up from the prior year.
- Liabilities and Shareholders Equity reached $199.2 million in Q4 2025 per VMD's latest filing, down from $202.4 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $202.4 million in Q3 2025 to a low of $111.0 million in Q2 2021.
- Average Liabilities and Shareholders Equity over 5 years is $146.8 million, with a median of $149.3 million recorded in 2023.
- Peak YoY movement for Liabilities and Shareholders Equity: decreased 1.04% in 2021, then surged 32.34% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $118.0 million in 2021, then fell by 0.78% to $117.0 million in 2022, then skyrocketed by 32.34% to $154.9 million in 2023, then increased by 14.32% to $177.1 million in 2024, then grew by 12.47% to $199.2 million in 2025.
- Per Business Quant, the three most recent readings for VMD's Liabilities and Shareholders Equity are $199.2 million (Q4 2025), $202.4 million (Q3 2025), and $184.6 million (Q2 2025).